These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 24678935)

  • 81. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
    J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature.
    Simonsen AH; Kuiperij B; El-Agnaf OM; Engelborghs S; Herukka SK; Parnetti L; Rektorova I; Vanmechelen E; Kapaki E; Verbeek M; Mollenhauer B
    Biomark Med; 2016; 10(1):19-34. PubMed ID: 26314196
    [TBL] [Abstract][Full Text] [Related]  

  • 83. miRNAs Regulation and Its Role as Biomarkers in Endometriosis.
    Marí-Alexandre J; Sánchez-Izquierdo D; Gilabert-Estellés J; Barceló-Molina M; Braza-Boïls A; Sandoval J
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771608
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Circulating miRNAs: a new generation of anti-doping biomarkers.
    Leuenberger N; Robinson N; Saugy M
    Anal Bioanal Chem; 2013 Dec; 405(30):9617-23. PubMed ID: 24077830
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The involvement of microRNAs in neurodegenerative diseases.
    Maciotta S; Meregalli M; Torrente Y
    Front Cell Neurosci; 2013 Dec; 7():265. PubMed ID: 24391543
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
    Coleman BM; Hill AF
    Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.
    Gonzalez-Cuyar LF; Sonnen JA; Montine KS; Keene CD; Montine TJ
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):455-63. PubMed ID: 21725901
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT; Liu CG; Gao SC; Zhang Y; Wang PC
    Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review.
    Kacperska MJ; Walenczak J; Tomasik B
    Adv Clin Exp Med; 2016; 25(4):775-9. PubMed ID: 27629854
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Plasma microRNAs as biomarkers for myotonic dystrophy type 1.
    Perfetti A; Greco S; Bugiardini E; Cardani R; Gaia P; Gaetano C; Meola G; Martelli F
    Neuromuscul Disord; 2014 Jun; 24(6):509-15. PubMed ID: 24679513
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Long non-coding RNAs in neurodegenerative diseases.
    Yang S; Yang H; Luo Y; Deng X; Zhou Y; Hu B
    Neurochem Int; 2021 Sep; 148():105096. PubMed ID: 34118305
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Circulating microRNAs in Neurodegenerative Diseases.
    Grasso M; Piscopo P; Crestini A; Confaloni A; Denti MA
    Exp Suppl; 2015; 106():151-169. PubMed ID: 26608203
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.
    Nuzziello N; Ciaccia L; Liguori M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892254
    [No Abstract]   [Full Text] [Related]  

  • 97. Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.
    Maiti TK; Konar S; Bir S; Kalakoti P; Bollam P; Nanda A
    Neurosurg Focus; 2015 Nov; 39(5):E3. PubMed ID: 26646927
    [TBL] [Abstract][Full Text] [Related]  

  • 98. ExcellmiRDB for translational genomics: a curated online resource for extracellular microRNAs.
    Barupal JK; Saini AK; Chand T; Meena A; Beniwal S; Suthar JR; Meena N; Kachhwaha S; Kothari SL
    OMICS; 2015 Jan; 19(1):24-30. PubMed ID: 25562198
    [TBL] [Abstract][Full Text] [Related]  

  • 99. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
    Sørensen SS; Nygaard AB; Christensen T
    Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.
    Shah SZA; Zhao D; Hussain T; Sabir N; Yang L
    Front Aging Neurosci; 2018; 10():139. PubMed ID: 29867448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.